SLB
46
2
EMR
50
2
JNJ
42
-2
XYL
35
2
PYPL
41
2
KMI
69
4
TSCO
45
2
MAS
58
2
LMT
27
-2
SEE
45
-4
CNP
44
8
ZBH
59
2
THC
62
2
KHC
22
-3
CHD
42
-3
UPS
27
-5
GRMN
68
-2
F
40
5
ADI
47
-2
CMG
57
-6
SLB
46
2
EMR
50
2
JNJ
42
-2
XYL
35
2
PYPL
41
2
KMI
69
4
TSCO
45
2
MAS
58
2
LMT
27
-2
SEE
45
-4
CNP
44
8
ZBH
59
2
THC
62
2
KHC
22
-3
CHD
42
-3
UPS
27
-5
GRMN
68
-2
F
40
5
ADI
47
-2
CMG
57
-6
Financhill
Back

Kiniksa Pharmaceuticals International PLC Vs. Neurogene Industry Stock Comparison

Sell
32

KNSA
Kiniksa Pharmaceuticals International PLC

Last Price:
21.48
Seasonality Move:
20.18%
Buy
75

NGNE
Neurogene

Last Price:
57.87
Seasonality Move:
58.98%
Sell
32
Kiniksa Pharmaceuticals International PLC (KNSA) is a Sell

Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?

  • The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $21.48. The Score for KNSA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • KNSA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Neurogene (NGNE) is a Buy

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $66.00. The Score for NGNE is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • NGNE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KNSA Stock Price Chart

What is Kiniksa Pharmaceuticals International PLC's stock price today?

  • The Kiniksa Pharmaceuticals International PLC share price today is $21.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing selling pressure, which indicates risk of future bearish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $66.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NGNE is experiencing slight buying pressure.

KNSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 29.68 Sell
Chaikin Money Flow: -400216 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.5 - 26.86) Sell
Bollinger Bands (100): (21.02 - 26.72) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.06 Buy
Relative Strength Index (14 RSI): 75.97 Buy
Chaikin Money Flow: 176225 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.28 - 53.36) Buy
Bollinger Bands (100): (34.64 - 46.72) Buy

KNSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.34 Sell
20-day SMA: 25.29 Sell
50-day SMA: 25.31 Sell
200-day SMA: 21.54 Sell
8-day EMA: 23.64 Sell
20-day EMA: 24.73 Sell
50-day EMA: 24.86 Sell
200-day EMA: 22.03 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.43 Buy
20-day SMA: 49.56 Buy
50-day SMA: 43.32 Buy
200-day SMA: 37.93 Buy
8-day EMA: 50.65 Buy
20-day EMA: 48.54 Buy
50-day EMA: 44.96 Buy
200-day EMA: 36.96 Buy

Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.91 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $1.11 per share.

Kiniksa Pharmaceuticals International PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):